Hypoxic tumor tissue

Hypoxic tumor tissue refers to regions within solid tumors where oxygen levels are critically reduced due to abnormal vasculature or increased metabolic demand[4][6]. This microenvironment profoundly alters tumor cell biology, promoting therapy resistance, genetic instability, angiogenesis, immunosuppression, and aggressive behavior[2][5][6][4][1]. Tumor hypoxia is mediated by intrinsic and extrinsic factors and induces a spectrum of molecular responses, especially through hypoxia-inducible factors (HIFs), which regulate numerous genes involved in metabolism, cell survival, angiogenesis, and immune evasion[2][5][1]. Tumor hypoxia is a key obstacle in effective cancer therapy and is actively investigated as a biomarker and as a target for therapeutic intervention[4][5].

Other names

Tumor hypoxiaHypoxic tumor microenvironmentLow oxygen tumor areasHypoxia in solid tumors

Hypoxia-activated prodrugs: selectively cytotoxic under hypoxic conditions - VTAs/angiogenesis inhibitors: reduce blood supply to tumor, modifying degree of hypoxia - HIF pathway inhibitors: block cellular adaptation to low oxygen - Oxygen modifiers: increase oxygenation to sensitize tumors to therapy